Published: October 25, 2019

Introduction {#sec1}
============

The kidney is essential for metabolic waste excretion, the homeostatic balance of tissue fluids (water, salt, and pH), blood pressure and cell composition, and bone development and metabolism. Filtration is performed within the renal corpuscles (RCs) by a highly structured cellular device. This comprises a convoluted fenestrated glomerular endothelium supported by mesangial myofibroblasts that releases a plasma filtrate that enters the nephron between slit diaphragms generated by the foot processes of tightly adherent podocytes. Establishment of the glomerular filter is initiated by a stereotypic recruitment of pioneering endothelial cells to the developing podocytes followed secondarily by interstitial cells into the glomerular cleft of Comma and S-Shaped bodies (CSBs and SSBs) and sequential capillary formation ([Figures 1](#fig1){ref-type="fig"}A and 1B). Podocytes support development and maintenance of the glomerular vasculature via VEGFA ([@bib19], [@bib90]), whereas endothelial-derived PDGF signals promote mesangial development ([@bib5], [@bib47]) before RC maturation ([Figure 1](#fig1){ref-type="fig"}C) ([@bib45], [@bib91]). Single gene mutations resulting in end-stage renal disease cluster in genes showing podocyte-enriched expression, highlighting the central role of podocytes in normal kidney function ([@bib7], [@bib110]). Advances in pluripotent stem cell-derived kidney organoid systems support parallel efforts to mechanistically dissect human kidney development to gain new insights into developmental programs relevant to treating or modeling disease states or generating functional systems ([@bib93], [@bib60], [@bib99], [@bib92], [@bib13]). A human-focused understanding of kidney development will complement other mammalian model systems to maximize effective application, predict new disease relationships, and identify novel developmental mechanisms ([@bib13], [@bib49], [@bib50], [@bib51], [@bib55], [@bib100]).Figure 1Schematic Model of RC Development(A) Differentiating NPCs epithelialize to form a renal vesicle with distal/proximal polarity. Nephron morphogenesis progresses through CSB and SSB stages concomitant with the recruitment and invasion of mesenchymal endothelial and interstitial cells to the glomerular cleft, which is lined by developing podocytes. Podocyte-derived VEGFA signaling to glomerular endothelial cells and PDGF secreted by endothelial cells acting on adjacent mesangial precursors are critical for the development, maintenance, and function of glomerular filtration.(B) Immunostaining showing incremental stages of glomerular capillary tuft development starting with invasion of PECAM1+ endothelial cells (yellow) followed by PDGFRB + interstitial cells (cyan) into the glomerular cleft (left to right panels).(C) Immunohistochemical staining of distinct stages of RC development labeling WT1+ PE, WT1+ podocytes colocalized with VEGFA (cyan arrowhead), and PECAM1+ endothelium colocalized with PDGF (red arrowhead).(Scale bars, 25 *μ*m). Prox, Proximal Nephron; Pod, Podocytes; PE, Parietal Epithelium; End, Endothelium; CSB, Comma-Shaped Body; CLN, Capillary Loop Nephron; RC, Renal Corpuscle.

Results {#sec2}
=======

Single-Nucleus Interrogation of Human Fetal Kidney {#sec2.1}
--------------------------------------------------

To generate insights into RC formation, we applied snDrop-seq to transcriptionally profile nuclei isolated from human fetal kidneys ([Figure 2](#fig2){ref-type="fig"}A). Our group, and others, have captured single-nuclear transcriptomes from other challenging tissues including postmortem adult brain ([@bib37], [@bib39]) resolving distinct cell types ([@bib38], [@bib102]). The benefits of the nuclear approach are that cryopreserved tissue with potentially clinical value are compatible and epithelialized cells including those of sieved mature RCs are more accessible than by enzymatic cell dissociation methods required for whole cell. Podocytes are consistently under-represented (or missing) from prominent large kidney single cell RNA sequencing (RNA-seq) datasets ([@bib1], [@bib74]). Furthermore, our previous studies were unable to sufficiently access epithelialized cell types beyond SSB using an enzymatic cortical digestion method ([@bib48], [@bib49], [@bib51]). To this end, we processed nephrogenic cortex and RCs from 13- to 16.5-week human fetal kidney samples that incorporated all stages of RC development to active filtering nephrons ([Figures 2](#fig2){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}, [Table S1](#mmc2){ref-type="supplementary-material"}). Nuclear RNA preferentially detects genes with high intron count compared with whole-cell RNA, leading to a systemic biased sensitivity toward genes that may escape detection in conventional single-cell approaches. Variable numbers of nuclei were obtained from each sample; whether the variation in number of nuclei reflects biological variability among the samples or technical variability in the procedures is not clear. Altogether, we generated data on 7,018 single nuclei from these combined samples sequenced to an average depth of 10,298 useful reads per nucleus ([Table S1](#mmc2){ref-type="supplementary-material"}). This permitted detection of a median of 879 unique transcripts and 707 genes per nucleus, with genomic mapping rates showing the expected higher proportion of reads corresponding to intronic sequences ([Table S1](#mmc2){ref-type="supplementary-material"}), as previously observed.Figure 2Single-Nucleus RNA Sequencing of the Developing Human Kidney and Pseudotemporal Ordering Resolves Major Cell Types and Informs on Podocyte Developmental Programs(A) An overview of the snDrop-seq pipeline on fetal kidney samples ([Table S1](#mmc2){ref-type="supplementary-material"}) including dissociated kidney cortical cells (14 and 16 weeks) and sieved glomeruli (13 and 15 weeks).(B) Combined expression data (four individuals over five experiments) visualized by UMAP dimensional reduction showing 18 distinct cellular populations encompassing the nephrogenic, interstitial, endothelial, and immune cell types. Cell type annotations and associated select marker genes are indicated for each cluster.(C) Violin plots showing expression values for select broad or cell-type specific marker genes. For each cluster, the number of datasets (SN), average number of transcripts (UMI), and average number of genes detected are indicated.(D) SWNE visualization of nephrogenic lineage cell clusters and associated non-negative factorization (NMF) identified gene signatures indicate cluster relationships.(E) Heatmap of top genes associated with each NMF state.(F) Trajectory analysis using Monocle of nephrogenic lineages showing developmental progression into distinct RC (proximal) and tubule (medial/distal) lineages. Corresponding heatmap indicating discrete gene expression intensity from the progenitor state (gray center line value) maturing to either RC (red tip value) or medial/distal (blue tip value) branches.(G) Trajectory analysis of the developing RC branch into either parietal or visceral (podocyte) epithelial cell types. Heatmap showing expression values of select marker genes progressing from differentiating NPCs (center, gray) to either parietal (red) or podocyte (blue) cell types.See also [Figures S1--S4](#mmc1){ref-type="supplementary-material"}.

To resolve the cell type composition, we analyzed transcriptional heterogeneity by grouping cells by gene-gene covariance (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}). This approach identified twelve nephrogenic, five interstitial, one immune, and one endothelial cluster ([Figure 2](#fig2){ref-type="fig"}A and [Tables S2](#mmc2){ref-type="supplementary-material"} and [S3](#mmc2){ref-type="supplementary-material"}). Clusters showed expression profiles and subgroup aggregations visualized with Uniform Manifold Approximation and Projection (UMAP) ([@bib3]), independent of technical batch effects ([Figures 2](#fig2){ref-type="fig"}B, 2C, and [S1](#mmc1){ref-type="supplementary-material"}). Cluster identification was supported by GO-Term analysis, immunohistological (protein-targeted) and *in situ* hybridization (mRNA-targeted) analysis with select known markers of mammalian kidney development, including LTBP1 ([@bib87], [@bib20]), CDH4 ([@bib15], [@bib84]), COL4A1 ([@bib11], [@bib12]), disease-related genes ESRRG ([@bib4], [@bib25]), PKHD1 ([@bib29], [@bib98]), and novel marker PAMR1 ([Figure S2](#mmc1){ref-type="supplementary-material"}, [Tables S4](#mmc2){ref-type="supplementary-material"} and [S5](#mmc2){ref-type="supplementary-material"}). To visualize and infer relationships between clusters we employed similarity weighted non-negative embedding (SWNE) analysis ([Figure 2](#fig2){ref-type="fig"}D) ([@bib101]). Nephron progenitor cells (NPCs) and mitotic NPCs (cNPC) clusters were related to two differentiated NPC (dNPC) clusters enriched from cortex ([Figure S1](#mmc1){ref-type="supplementary-material"}). Differentiated tubular clusters comprised medial/distal and proximal tubular identities ([Figure 2](#fig2){ref-type="fig"}D). DNPCs transitioned to parietal epithelium (PE), and podocyte clusters enriched in RC samples ([Figures 2](#fig2){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}). Interstitial clusters were composed of interstitial progenitor cells (IPCs), mitotic interstitium (cINT), and three populations containing two mesangial clusters enriched in RC samples (INT1-3) ([Figures 2](#fig2){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}).

Molecular Dissection of Podocyte Development {#sec2.2}
--------------------------------------------

Given the nucleating role of the podocyte in the development of a glomerular filter we hypothesized that transiently expressed genes during podocyte development could be important coordinating glomerular and mesangial cell programs. An unsupervised pseudotemporal analysis in Monocle was used to identify intermediates in the podocyte developmental pathway ([Figures 2](#fig2){ref-type="fig"}C--2E, [S3](#mmc1){ref-type="supplementary-material"}, and [S4](#mmc1){ref-type="supplementary-material"}) ([@bib80]). Monocle analysis predicted that NPCs transitioned to dNPCs that expressed *PAX8*, *JAG1*, and *LHX1* ([@bib73], [@bib42], [@bib78]) ([Figures 2](#fig2){ref-type="fig"}D--2G, [Tables S6](#mmc2){ref-type="supplementary-material"} and [S7](#mmc2){ref-type="supplementary-material"}). *Lhx1* plays a key early role in mouse podocyte programs and mutations in LHX1 associated with congenital anomalies of the kidney and urinary tract (CAKUT) syndrome ([@bib31], [@bib6], [@bib51]). Additionally, *JAG1* and *PAX8* are two markers of early nephron that are involved in kidney development and disease ([@bib6], [@bib65], [@bib78], [@bib50], [@bib52], [@bib10], [@bib77]). DNPCs bifurcated between medial/distal and proximal identities including podocytes ([Figures 2](#fig2){ref-type="fig"}F, [S3](#mmc1){ref-type="supplementary-material"}, and [S4](#mmc1){ref-type="supplementary-material"}, [Table S6](#mmc2){ref-type="supplementary-material"}). Glomerulus-related GO Terms were associated with the proximal branch, whereas cytoskeletal processes were associated with the medial/distal branch ([Tables S7--S11](#mmc2){ref-type="supplementary-material"}). Monocle analysis of proximal transcriptomes bifurcated podocyte and PE trajectories ([Figures 2](#fig2){ref-type="fig"}F, 2G, and [S2](#mmc1){ref-type="supplementary-material"}E--S2E'). Global pseudotemporal analysis of this dataset identified eight temporally distinct gene sets (GS1--GS8) with distinct ontologies ([Figures 3](#fig3){ref-type="fig"}A and 3B, and [Table S12](#mmc2){ref-type="supplementary-material"}). At one end, NPCs (GS1) expressed *ROBO2* and *ECEL* ([@bib49]), whereas at the other end, mature podocytes (GS8) expressed *FOXC1, SYNPO, NPHS2* ([Table S12](#mmc2){ref-type="supplementary-material"}), key genes in mouse and human podocyte function ([@bib48], [@bib49], [@bib62], [@bib83], [@bib104], [@bib63], [@bib33], [@bib35], [@bib22], [@bib88]). GS6--GS8 gene-associated phenotypes included defects in ureteric bud, renal system, and podocyte foot processes accompanied with GO Terms for regulation of development, cell adhesion, and cell movement ([Figure 3](#fig3){ref-type="fig"}B and [Table S12](#mmc2){ref-type="supplementary-material"}).Figure 3Trajectory Analysis of Podocyte Lineage Cells Identifies Distinct Transient Gene Expression Signatures(A) Unidirectional trajectory of undifferentiated NPCs and podocyte lineage cells (see [Transparent Methods](#mmc1){ref-type="supplementary-material"}) identified in [Figure 2](#fig2){ref-type="fig"}G.(B) Identification of temporally significant stages of gene expression and their associated top gene ontology (GO) and mouse/human phenotype terms (select genes from each term are indicated). Cells are ordered according to the trajectory shown in (A).(C) Heatmap of gene expression values for select stage-specific and expressed factors during podocyte development for cells ordered as in (A).See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Examining these data for podocyte-derived, stage-specific developmental signals as potential organizers of the glomerular filter identified three expressed factors predicted to display partial temporal overlap: *BMP4* (GS6; a member of the BMP subfamily of TGFβ signals) ([@bib71]), *FBLN2* (GS7; a calcium-binding extracellular matrix protein of the fibulin family) ([@bib109]), and *NTN4* (GS8; a Netrin family member) ([Figure 3](#fig3){ref-type="fig"}C) ([@bib106]). *In situ* hybridization demonstrated each exhibited expression in podocytes (but also other cell types) surrounding the glomerular cleft in conjunction with angioblast recruitment, although their spatiotemporal profiles differed ([Figure 4](#fig4){ref-type="fig"}A). In particular, *FBLN2* was detected at high levels in the earliest podocyte precursors, continued throughout RC development, but terminated in the functional RC ([Figure 4](#fig4){ref-type="fig"}A). FBLN2 was detected within the glomerular cleft and angioblasts produced PERLECAN/HSPG2, a potential interaction partner for FBLN2([@bib8]) ([Figures 4](#fig4){ref-type="fig"}B and 4C). UNC5B, a surface receptor for NTN4 known to be involved in diabetic nephropathy ([@bib54], [@bib27], [@bib43], [@bib82], [@bib97]), was also detected on the angioblast ([Figures 4](#fig4){ref-type="fig"}D and 4E), continuing into periglomerular endothelial cells of mature RCs, and on parietal epithelial cells that encapsulated the RC ([Figures 4](#fig4){ref-type="fig"}D and 4F). Analysis of phospho-SMAD and ERK staining, respectively, suggests evidence including but not limited to potential activation of BMP and FGF signaling within the vascular/mesangial population invading the glomerular cleft ([Figures 4](#fig4){ref-type="fig"}G and 4H). These data support potential roles for FBLN2, NTN4, and BMP4 in RC assembly from the initial stages of endothelial and interstitial recruitment ([Figure 4](#fig4){ref-type="fig"}I).Figure 4Spatiotemporal Mapping of the Expression of Genes Encoding Podocyte-Expressed Factors and Predicted Endothelial and Interstitial Cell Interactions(A--E) (A) *In situ* hybridization for *FBLN2, NTN4*, and *BMP4* indicating gene expression (arrowheads) during intermediate phases of proximal fate to podocyte development. Arrowheads point to expression in developing podocytes that is absent in mature RCs, with the exception of NTN4, which is expressed in periglomerular vasculature and at lower levels in mature podocytes. Immunostaining in SSB and RC for (B) FBLN2, (C) HSPG2, (D) NTN4, (E) UNC5B, and indicated markers.(F--H) (F) *In situ* hybridization of *UNC5B*. Phospho-SMAD1/5- (G) and phospho-ERK- (H) positive cells (arrowheads) showing labeling of infiltrating cells into the glomerular cleft in SSB and in RCs (scale bars, 25 *μ*m). Dist, Distal Nephron; Med, Medial Nephron; Prox, Proximal Nephron; Pod, Podocytes; PE, Parietal Epithelium; SSB, S-Shaped Body; RC, Renal Corpuscle.(I) Dot pots showing relative expression (blue color intensity) and relative number of positive nuclei (dot size) for extracellular matrix and cell signaling genes found within clusters identified in [Figure 1](#fig1){ref-type="fig"}A.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Endothelial and Interstitial Cell Responses to Podocyte-Derived Expressed Factors {#sec2.3}
---------------------------------------------------------------------------------

NTN4 and BMP4 are known to have multiple roles in kidney and glomerular disease and development ([@bib18], [@bib56], [@bib57], [@bib69], [@bib70], [@bib81], [@bib94], [@bib97]), and non-glomerular associated Fbln2 expression has been reported in the mouse kidney ([@bib72]); however, no specific role has been attached to any of these factors in coordinating glomerular endothelial or mesangial programs in the human kidney. To explore the function of these factors on human vascular and mesangial cell development, biologically relevant primary endothelial and interstitial cell types were isolated from the human fetal kidney by enzymatic dissociation of the cortical region and antibody specific enrichment (anti-VECAD1, endothelial; anti-PDGFRB, interstitial) ([Figure 5](#fig5){ref-type="fig"}A) and tested for high-affinity responses to nanomolar concentrations of specific factors informed by the previous literature. As expected from published studies ([@bib2]), VEGFA promoted endothelial cell migration through a cell permeable membrane, reflecting *VEGFA*\'s known actions in facilitating early assembly of the glomerular vasculature ([Figure 1](#fig1){ref-type="fig"}), increased angiogenic tubule formation in Matrigel ([Figures 5](#fig5){ref-type="fig"}B and 5C), and enhanced endothelial cell proliferation ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Interestingly, FBLN2 and NTN4 but not BMP4 also increased endothelial cell migration and angiogenic tube formation but did not alter proliferation suggesting a partial overlap with VEGFA-stimulated activities ([Figures 5](#fig5){ref-type="fig"}B--5E, [S5](#mmc1){ref-type="supplementary-material"}A, and S5B). NTN4 has been shown to elicit context-dependent angiogenic or anti-angiogenic responses consistent with observations here ([@bib40], [@bib64], [@bib27]). FBLN2 has been linked to cell adhesion ([@bib76]), and the transient accumulation in the matrix surrounding migrating endothelial cells in the glomerular cleft is consistent with matrix interactions promoting adhesion and cell spreading ([Figures 4](#fig4){ref-type="fig"}B, 4D, and [S5](#mmc1){ref-type="supplementary-material"}C). To examine FBLN2 action further, a scratch assay was performed on a confluent population of endothelial cells to determine if FBLN2 influences cell spreading at the leading edge, a sensitive and quantitative assay of general cell motility and cytoskeletal spreading in a homogeneous environment that was previously described ([@bib105]). A marked increase in lamellar extensions was observed in the presence of FBLN2 and this response was abrogated by co-incubation with Endorepellin, an inhibitory subunit of HSPG2 that is thought to inhibit FBLN2-HSPG2 interactions and is generally anti-angiogenic ([@bib79], [@bib58], [@bib8], [@bib17]) ([Figures 5](#fig5){ref-type="fig"}F and 5G). Additionally, endothelial cells preferentially adhered to an FBLN2-coated surface, an interaction that was strongly inhibited on addition of Endorepellin ([Figures 5](#fig5){ref-type="fig"}H and 5I). Together these support a role for podocyte-expressed FBLN2 acting at least in part through endothelial-produced HSPG2 in promoting outgrowth, migration, and adhesion of endothelial cells in glomerular morphogenesis. Interestingly, mouse Fbln2 does not show similar dynamic podocyte restricted activity in RC development and is instead restricted to the apical domain of tubular epithelia ([Figure S5](#mmc1){ref-type="supplementary-material"}D). A closely related gene Fbln1 is expressed in the glomerular cleft in mouse but is widely detected, whereas FBLN1 is nearly absent in human kidney tissues suggesting a marked species difference in the regulation of both genes with respect to podocyte development ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Although VEGFA, FBLN2, and NTN4 may all act together at early stages of glomerular morphogenesis, only VEGFA and NTN4 are likely to play a continuing role in the maintenance of the glomerular network.Figure 5Chemotactic, Angiogenic, and Mesangial-Inductive Effects of FBLN2, NTN4, and BMP4(A) Isolation of primary HFK endothelial and interstitial cells, subculture.(B) Schematic of migration assay indicating input cells migrating through permeable filter to chemoattracting factor in the lower chamber.(C) Quantitation of endothelial, interstitial, or mixed migration across permeable membrane in response to factors indicated.(D--G) (D) Schematic and quantification of endothelial tube assay in response to factors indicated with (E) representative images of tube formation and dotted line highlighting tubes. Scale bars, 0.5 mm. (F) Quantification and (G) representative images of endothelial or interstitial cell lamellar extension length and area (yellow) in response and to factors indicated (scale bars, 50 *μ*m).(H and I) (H) Representative images and (I) quantitation of endothelial cell adhesion to surfaces coated with factors indicated (scale bars, 20 *μ*m).(J) Pseudotemporal upregulation of indicated genes during Interstitial cluster INT1/2 differentiation. Immunohistochemical staining of phospho-SMAD1/5 and PDGFRB costaining in renal vesicles, S-Shaped Bodies, and RCs showing colocalization in mesangial cells. Immunofluorescent staining of PDGFRB, GATA3, MAFB, and REN showing PDGFRB+/GATA3+ interstitial cells recruited to SSBs. REN + cells identify juxtaglomerular cells (Scale bars, 50 μm).(K and L) (K) Quantification and (L) representative images of BMP4 induction of GATA3 and PDGFRB with or without the presence of pSMAD or MAPK inhibition of interstitial cells after 12 h (scale bars, 25 *μ*m).Data are represented as mean ± SEM. One asterisk (\*) indicates p value smaller than 0.05 (p \< 0.05). Two asterisks (\*\*) indicate p value smaller than 0.01 (p \< 0.01). Three asterisks (\*\*\*) indicate p value smaller than 0.001 (p \< 0.001). See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Podocyte-directed actions on the interstitial to mesangial cell transition are not well understood. Genetic studies in the mouse have shown endothelial cell-derived *PDGFB* acts through mesangial cell *PDGFRB* to promote mesangial cell-dependent formation of the glomerulus ([@bib5]). PDGF pathway action plays a broader role in regulating pericytes, a myofibroblast-like cell type interacting with non-glomerular vasculature, which shares a common origin from interstitial progenitor cells ([@bib32]). To initially determine if PDGFRB + cortical interstitial cells show expected responses *in vitro*, we examined the effects of PDGFB. PDGFB addition enhanced interstitial cell migration across a cell permeable membrane ([Figures 5](#fig5){ref-type="fig"}B and 5C), and the proliferative stimulus invoked by PDGFB was inhibited by DMPQ ([@bib53]), a specific PDGFRB inhibitor ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). Thus, the *in vitro* system replicated PDGF/PDGFRB interactions. Interestingly, interstitial cells were also stimulated to migrate by FBLN2 similarly to endothelial cells by a yet unclear mechanism ([Figure 5](#fig5){ref-type="fig"}C). Interstitial trajectory analysis showed that interstitial progenitor cells generate different interstitial cell types (INT-1/INT-2/INT-3). In conjunction with the developmental progression, differential gene expression analysis predicted an upregulation of the BMP receptor *BMPR1B* and the transcriptional regulatory factor *GATA3,* involved in mesangial differentiation ([@bib36]) in INT-1/INT-2 cells ([Figure 4](#fig4){ref-type="fig"}H and [Table S13](#mmc2){ref-type="supplementary-material"}), and an upregulation of BMP signaling inhibitors in INT-3 cells, a yet uncharacterized interstitial cell type ([Tables S14](#mmc2){ref-type="supplementary-material"} and [S15](#mmc2){ref-type="supplementary-material"}). Both gain and loss of function of *Bmp4* in mouse podocytes result in glomerular capillary defects suggesting that precise regulation of BMP signaling is critical in RC programs ([@bib94]).

Consistent with a role for BMP signaling in human glomerular development, cells in the glomerular cleft exhibited phospho-SMAD1/5 activity ([Figures 5](#fig5){ref-type="fig"}J and [S5](#mmc1){ref-type="supplementary-material"}F). Linked nuclear GATA3 raised the possibility that GATA3 may be a target of BMP signaling. In support of this conjecture, exogenous BMP4 induced expression of ID1, an established BMP target ([@bib28], [@bib107]), in cultured interstitial cells, and elevated GATA3 levels ([Figures 5](#fig5){ref-type="fig"}K, 5L, and [S5](#mmc1){ref-type="supplementary-material"}E). To examine a possible BMP4 GATA3 link, LDN-193189 was added to inhibit BMP type 1 receptor/phospho-SMAD activity in the presence of BMP4 ([@bib9], [@bib14], [@bib108]). As expected, LDN-193189 inhibited expression of the BMP-target *ID1* ([Figure S5](#mmc1){ref-type="supplementary-material"}E). In contrast, qPCR measurement indicated that *GATA3* expression was unaltered suggesting that BMP4 elevation of GATA3 is independent of pSMAD1/5 activity ([Figure S5](#mmc1){ref-type="supplementary-material"}E). BMPs have also been reported to act through Smad-independent ERK, p38, JNK, and SAPK MAPK pathways ([@bib9], [@bib70], [@bib44], [@bib26], [@bib68]). To address this possibility, the UO126 MEK inhibitor was added to block ERK activity in the presence of BMP4. As expected, UO126 did not perturb BMP4-induced ID1 levels, but GATA3 levels were reduced ([Figure S5](#mmc1){ref-type="supplementary-material"}E). However, UO126 alone was sufficient to increase GATA3 to a similar level as BMP4 treatment suggesting that multiple context-dependent signaling inputs may be involved in GATA3 regulation. BMPs are known to induce GATA3 ([@bib75], [@bib46]) and act synergistically with p38 and ERK in some contexts ([@bib9], [@bib103], [@bib89]). There are likely other sources of BMP4 ([@bib81]) and other signals that regulate GATA3 in the mesangium ([@bib59], [@bib96]). *BMP7* is involved in kidney development and disease ([@bib18], [@bib20], [@bib23], [@bib69]) ([Figures 4](#fig4){ref-type="fig"}G, 4H, [S5](#mmc1){ref-type="supplementary-material"}F, and S5G), is expressed in later podocyte development (GS7) ([Figure 3](#fig3){ref-type="fig"}B), and along with BMP4 can induce pERK1/2 and p38 in mouse mesangial cells ([@bib68]) suggesting mesangial BMP responsiveness is likely conserved in mammals.

Discussion {#sec3}
==========

The kidney\'s filter is a key target for re-building kidney function. The findings here inform on cell interactions that may facilitate this goal ([@bib95], [@bib61]). The single-nuclear transcriptional profiling reported here complements approaches from our group and others ([@bib1], [@bib13], [@bib30], [@bib48], [@bib49], [@bib51], [@bib55], [@bib66], [@bib85], [@bib99], [@bib100], [@bib102]) to identify previously unappreciated factors mediating formation of the renal filter. FBLN2, NTN4, and BMP4 are expressed by developing podocytes concomitant with angioblast and interstitial cell recruitment expressing cognate interacting factors indicating related and potentially concerted actions in the establishment of the glomerular filter ([Figure 1](#fig1){ref-type="fig"}). The *in vitro* studies support their actions on endothelial or mesangial cell programs. Mutations for mouse Fibulins 1, 3, 4, and 5 have strong pleiotropic phenotypes including hemorrhages in multiple tissues and defects in the capillaries heart, lung, and kidney including impaired formation of glomerular capillaries and abnormal cell junctions in *Fbln1* mutants ([@bib34]). However, in mouse, *Fbln2* mutants are viable with no reported kidney phenotype and *Fbln2* is localized quite differently in the mouse kidney ([@bib67]) when compared with its human ortholog. We hypothesize that developmentally restricted expression of *FBLN2* may perform highly specialized functions directing glomerular vascularization in human kidney development replacing some of the functions of Fbln1 in mouse. Thus far, human *FBLN2* has not been linked to human disease or kidney function ([@bib16]) but could be uncovered by genome-wide association study (GWAS)-powered investigations. However, FBLN2 has been shown to exhibit properties in non-kidney systems similar to those demonstrated here. FBLN2 regulates invasion, migration, and/or adhesion of astrocytes, keratinocytes, and cancer cells and is linked to wound healing cells ([@bib16], [@bib21], [@bib41], [@bib67], [@bib86]). *FBLN2* also shows alternate splice isoform abundance in mouse versus human ([@bib24], [@bib76]). In contrast, disruption of *Bmp4* leads to mesangial and RC defects in the mouse ([@bib94]), suggesting that BMP4\'s function in human and mouse may be a conserved requirement for glomerulus development. A current goal for kidney translational research is to vascularize pluripotent-derived kidney tissues *in vitro* and replicate glomerular function but has thus far eluded our best efforts and impedes clinical application of kidney organoids. Thus, there is an acute need for knowledge of mechanisms sufficient to direct vascularization of kidney tissue types *in vitro*, and our work presented here has identified three potential candidates. Future studies will focus on regulation of FBLN2, NTN4, and BMP4 to induce *in vitro* assembly of glomerular capillary formation, maintenance, and function. In conclusion, these studies highlight the power of single-cell analysis in the understanding of human organogenesis, predicting cell interactions and distinct pathways of action not observed in the mouse model system.

Limitations of the Study {#sec3.1}
------------------------

Deidentified primary human fetal kidney tissue for nuclei profiling, imaging, and *in vitro* culture were received on a case-by-case basis. Limitations on the availability of tissue samples and variability in sample age and sex precluded a detailed mechanistic follow-up of the preliminary findings of BMP4-mediated regulation of mesangial GATA3 expression. Additional studies will be essential to clarify the pathway(s) of action of the signaling activities identified here and how these factors may cooperate with a broader range of signals within the developing glomerular environment. Here, GATA3 upregulation within interstitial cells could facilitate unbiased systematic screening to broadly explore pathway actions in future work.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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